Another good review of the “new” coronavirus in Science Magazine.
People should remember that if there were a concern about a change in vaccine efficacy due to a new virus variant, the RNA vaccines could have a second RNA included to cover that variant in short order. You can simply synthesize another RNA corresponding to the new variant and include it in the vaccine, so that both proteins are produced.
This is one of the wonders of these vaccines; they can be modified as soon as the sequence is known!
Pandemic Pondering 
I am glad you put that positive note about the RNAA vaccines in your blog; the Science magazine article is a little worrying. Question — Is it the case that as the vaccine rolls out and the rate of new infections drops as a result, the mutation rate will slow down because there are fewer quadrillion trillion of viruses out there replicating themselves?
*From:* Pandemic Pondering *Sent:* Monday, December 21, 2020 10:09 AM *To:* pkp@nbgroup.com *Subject:* [New post] Science Magazine’s take on the “London” virus.
jbakerjrblog posted: ” Another good review of the “new” coronavirus in Science Magazine. People should remember that if there was a concern about a change in vaccine efficacy due to a new virus variant, the RNA vaccines could have a second RNA included to cover that variant”
LikeLiked by 1 person